Inhibition of drug transport by genistein in multidrug-resistant cells expressing P-glycoprotein

Biochemical Pharmacology

Volumn 53, Issue 1, 1997, Pages 89-93

  Castro, Ariel F ^a   Altenberg, Guillermo A ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

drug transport; MRP; multidrug resistance; phosphorylation; photoaffinity labeling; tyrosine kinase

Indexed keywords

AZIDOPINE; DAUNORUBICIN; FLAVONOID; GENISTEIN; GLYCOPROTEIN P; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN; RADIOISOTOPE; RHODAMINE 123;

ANIMAL CELL; ARTICLE; CELL LEVEL; CELL STRAIN 3T3; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG TRANSPORT; HUMAN; HUMAN CELL; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PHOTOAFFINITY LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL;

3T3 CELLS; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; DAUNORUBICIN; DRUG RESISTANCE, MULTIPLE; ENZYME INHIBITORS; GENISTEIN; HUMANS; ISOFLAVONES; MICE; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; P-GLYCOPROTEIN; PROTEIN-TYROSINE KINASES; RHODAMINE 123; RHODAMINES; TUMOR CELLS, CULTURED;

EID: 0031060647     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(96)00657-0     Document Type: Article

References (20)

1. Gottesman MM and Pastan I, Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Blochem 62: 385-427, 1993.
2. Cole SPC, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KG, Stewart AJ, Kurz EU, Duncan AMW and Deeley RG, Overexpression of a novel transporter gene in a multidrug-resistant human lung cancer cell line. Science 258: 1650-1654, 1992.
3. Broxterman HJ and Versantvoort CHM, Pharmacology of drug transport in multidrug resistant tumor cells. In: Alternative Mechanisms of multidrug Resistance in Cancer (Ed. Kellen JA, pp. 67-80. Birkhauser, Boston, 1995.
4. Cole SPC, Sparks KE, Fraser K, Loe DW, Grant CE, Wilson GM and Deeley RG, Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res 54: 5902-5910, 1994.
5. Versantvoort CHM, Schuurhuis GJ, Pinedo HM, Eekman CA, Kuiper CM, Lankelma J and Broxterman HJ, Genistein modulates the decreased drug accumulation in non-P-glycoprotein mediated multidrug resistant tumour cells. Br J Cancer 68: 939-946, 1993.
6. Versantvoort CHM, Broxterman HJ, Lankelma J, Feller N and Pinedo HM, Competitive inhibition by genistein and ATP dependence of daunorubicin transport in intact MRP overexpressing human small cell lung cancer cells. Biochem Pharmacol 48: 1129-1136, 1994.
7. Fairchild CR, Moscow JA, O'Brien EE and Cowan KH, Multidrug resistance in cells transfected with human genes encoding a variant P-glycoprotein and glutathione S-transferase-TT. Mol Pharmacol 37: 801-809, 1990.
8. Schneider E, Horton JK, Yang C-H, Nakagawa M and Cowan KH, Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance. Cancer Res 54: 152-158, 1994.
9. Altenberg GA, Vanoye CG, Horton JK and Reuss L, Unidirectional fluxes of rhodamine 123 in multidrug-resistant cells: Evidence against direct drug extrusion from the plasma membrane. Proc Nat Acad Sci USA 91: 4654-4657, 1994.
10. Han ES, Vanoye CG, Altenberg GA and Reuss L, P-glycoprotein-associated chloride currents revealed by specific block by an anti-P-glycoprotein antibody. Am J Physiol 270: C1370-C1378, 1996.
11. Zamora JM, Pearce HL and Beck WT, Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cells. Mol Pharmaeol 33: 454-462, 1988.
12. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N. Shibuya M and Fukami Y, Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 262: 5592-5595, 1987.
13. Tamai I and Safa AR, Azidopine noncompetitively interacts with vinblastine and cyclosporin A binding to P-glycoprotein in multidrug resistant cells. J Biol Chem 266: 16796-16800, 1991.
14. Ma L, Krishnamachary N and Center MS, Phosphorylation of the multidrug resistance associated protein gene encoded protein P190. Biochemistry 34: 3338-3343, 1995.
15. Germann UA, Chambers TC, Ambudkar SV, Pastan I and Gottesmann MM, Effects of phosphorylation of P-glycoprotein on multidrug resistance. J Bioenerg Biomembr 27: 53-61, 1995.
16. Onoda T, linuma H, Sasaki Y, Hamada M, Issiki K, Naganawa H, Takeuchi T, Tatsuta K and Umezawa K, Isolation of a novel tyrosine kinase inhibitor, Iavendustin A, from Streptomyces griseolavendus. J Nat Prod 52: 1252-1257, 1989.
17. Twentyman PR, Rhodes T and Rayner S, Comparison of rhodamine 123 accumulation and efflux in cells with P-glycoprotein-mediated and MRP-associated multidrug resistance phenotypes. Eur J Cancer 30: 1360-1369, 1994.
18. Critchfield JW, Welsh CJ, Phang JM and Yeh GC, Modulation of Adriamycin® accumulation and efflux by flavonoids in HCT-15 colon cells. Activation of P-glycoprotein as a putative mechanism. Biochem Pharmacol 48: 1437-1445, 1994.
19. Poore CM, Lopaczynska J, Yeh GC and Phang JM, Flavonoid-stimulated hydroperoxide formation is linked to Pgp function in multidrug resistant (MDR) human breast cancer MCF-7 cells. Proc Am Assoc Cancer Res 36: A1946, 1995.
20. Scambia G, Ranelletti FO, Panici PB, De Vincenzo R, Bonanno G, Ferrandina G, Piantelli M, Bussa S, Rumi C, Cianfriglia M and Mancuso S, Quercitin potentiates the effect of Adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycorprotein as a possible target. Cancer Chemother Pharmacol 34: 459-464, 1994.